Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

Author：                

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.4, Iss.5, 2012-01, pp. : 1017-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma

By Nishida Masato   Tsunoda Hajime   Ichikawa Yoshihito   Yoshikawa Hiroyuki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 403-405

Springer Publishing Company

Access to resources Recommend Favorite

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

By Takano Masashi   Sugiyama Toru   Yaegashi Nobuo   Suzuki Mitsuaki   Tsuda Hiroshi   Sagae Satoru   Udagawa Yasuhiro   Kuzuya Kazuo   Kigawa Junzo   Takeuchi Satoshi   Tsuda Hitoshi   Moriya Takuya   Kikuchi Yoshihiro  

International Journal of Clinical Oncology, Vol. 12, Iss. 4, 2007-08 ,pp. : 256-260

Springer Publishing Company

Access to resources Recommend Favorite

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

By Ueda Shinya   Hironaka Shuichi   Boku Narikazu   Fukutomi Akira   Yoshino Takayuki   Onozawa Yusuke  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 203-207

Springer Publishing Company

Access to resources Recommend Favorite

Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer

By Ohara Tatsuru   Kobayashi Yoichi   Yoshida Ayako   Yoshioka Norihito   Yahagi Namiko   Kondo Haruhiro   Tozawa Akiko   Kiguchi Kazushige   Suzuki Nao  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1102-1106

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis

By Sakamoto Takeshi   Yasui Hirofumi   Boku Narikazu   Onozawa Yusuke   Hironaka Shuichi   Fukutomi Akira   Yamazaki Kentaro   Taku Keisei   Machida Nozomu   Todaka Akiko   Tomita Hideharu   Tsushima Takahiro   Taniguchi Hiroya   Hamauchi Satoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 287-293

Springer Publishing Company

Access to resources Recommend Favorite